MJardin Group (MJARF) Stock Price, News & Analysis

Company Overview

MJardin Group (OTCMKTS:MJARF) is a vertically integrated cannabis company focused on the cultivation, processing, branding and distribution of cannabis products in North America. The company operates through a network of subsidiaries that span the supply chain, including cultivation facilities, manufacturing operations and wholesale distribution channels. MJardin’s product portfolio encompasses a range of flower strains, concentrates, edibles and infused consumer packaged goods, all produced under rigorous quality-control standards.

In addition to its core cultivation and manufacturing activities, MJardin offers a suite of ancillary services to aspiring operators and established multi-state operators. These services include regulatory consulting, licensing support, operational advisory and brand development. Through MJardin Advisory, the company leverages its in-house expertise in compliance, packaging design, distribution logistics and point-of-sale merchandising to help clients bring products to market efficiently and in full compliance with state regulations.

MJardin’s footprint extends across key legal cannabis markets in the United States, with active operations in states such as Michigan, Nevada and California. The company has strategically partnered with local cultivators and dispensaries to expand its wholesale distribution network while also exploring opportunities in emerging East Coast markets. By aligning with regional operators, MJardin aims to secure shelf space for its branded products and establish supply agreements with leading dispensary chains and retail outlets.

Originally founded in 2016 as a licensed energy and technology firm, MJardin pivoted to the cannabis sector in response to accelerating market legalization. The company is led by an executive team with deep experience in consumer packaged goods, horticulture and regulatory affairs. Under the leadership of CEO Doug Drysdale, MJardin continues to refine its vertically integrated model and pursue long-term growth through strategic partnerships, innovative product development and a commitment to operational excellence.

Key Stats

• Today's Range: $0.0036 to $0.0036
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0036
• Volume: N/A
• Average Volume: 15,319 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

MJARF Stock Analysis - Frequently Asked Questions

How have MJARF shares performed this year?

MJardin Group's stock was trading at $0.0001 at the beginning of 2025. Since then, MJARF stock has increased by 3,500.0% and is now trading at $0.0036.

How do I buy shares of MJardin Group?

Shares of MJARF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:MJARF
• CIK: N/A
• Web: www.mjardin.com
• Phone: (720) 613-4019
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A